Assertio therapeutics announces sale of nucynta franchise to collegium pharmaceutical for $375.0 million

Assertio therapeutics announces sale of nucynta® franchise to collegium pharmaceutical for $375.0 million.assertio therapeutics inc - company intends to use cash proceeds to retire its outstanding debt.assertio therapeutics inc - collegium will pay assertio $375.0 million in cash at closing, less royalties paid to assertio in 2020.assertio therapeutics inc - collegium will also pay assertio for certain inventories and equipment relating to products.assertio therapeutics inc - company is also announcing that it is no longer pursuing development of long-acting cosyntropin.
ASRT Ratings Summary
ASRT Quant Ranking